Highlights and Quick Summary
- Capital expenditures for the quarter ending September 30, 2022 was $-759 Thousand (a -68.4% decrease compared to previous quarter)
- Year-over-year quarterly Capital expenditures decreased by -70.07%
- Annual Capital expenditures for 2021 was $-13.2 Million (a 76.19% increase from previous year)
- Annual Capital expenditures for 2020 was $-7.52 Million (a 184.99% increase from previous year)
- Annual Capital expenditures for 2019 was $-2.64 Million (a 21.12% increase from previous year)
- Twelve month Capital expenditures ending September 30, 2022 was $-6.56 Million (a -46.52% decrease compared to previous quarter)
- Twelve month trailing Capital expenditures decreased by -50.51% year-over-year
Trailing Capital expenditures for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $-6.56 Million | $-12.3 Million | $-12.1 Million | $-13.2 Million |
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capital expenditures of BridgeBio Pharma, Inc.
Most recent Capital expendituresof BBIO including historical data for past 10 years.Interactive Chart of Capital expenditures of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Capital expenditures for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-0.76 | $-2.4 | $-0.86 | – |
| 2021 | $-2.54 | $-6.46 | $-2.29 | $-1.96 | $-13.25 |
| 2020 | $-2.29 | $-0.55 | $-0.2 | $-4.48 | $-7.52 |
| 2019 | $-1.75 | $-0.38 | $-0.08 | $-0.43 | $-2.64 |
| 2018 | – | – | $-0.74 | $-1.44 | $-2.18 |
| 2017 | $-0.46 | – | – | – | $-0.46 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology